Does the prevalence of temporomandibular disorders increase as a result of tooth loss or prosthodontic rehabilitation? A national representative cross-sectional study
Dental and Medical Problems · 30.10.2026 · (5) · 1189-1197
DOI: 10.17219/dmp/211427 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Dental and Medical Problems, online erschienen am 30.10.2026. Verfasst von Emőke Márta Takács und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Temporomandibular Joint Disorders, Tooth Loss. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Prosthodontics, Semmelweis University, Budapest, Hungary.
Zitieren
APA
Takács, E. M., Süveges, I., Ambrus, S., Schmidt, P., Jász, B., Hermann, P., Körmendi, S., & Jász, M. (2026). Does the prevalence of temporomandibular disorders increase as a result of tooth loss or prosthodontic rehabilitation? A national representative cross-sectional study. Dental and Medical Problems, 1189-1197. https://doi.org/10.17219/dmp/211427
Vancouver
Takács EM, Süveges I, Ambrus S, Schmidt P, Jász B, Hermann P, et al. Does the prevalence of temporomandibular disorders increase as a result of tooth loss or prosthodontic rehabilitation? A national representative cross-sectional study. Dental and Medical Problems. 2026:1189-1197. doi:10.17219/dmp/211427
BibTeX
@article{Takcs2026,
author = {Takács, Emőke Márta and Süveges, Ibolya and Ambrus, Szilvia and Schmidt, Péter and Jász, Bálint and Hermann, Péter and Körmendi, Szandra and Jász, Máté},
title = {Does the prevalence of temporomandibular disorders increase as a result of tooth loss or prosthodontic rehabilitation? A national representative cross-sectional study},
journal = {Dental and Medical Problems},
year = {2026},
number = {5},
pages = {1189--1197},
doi = {10.17219/dmp/211427}
}
EUVIMED